abstract |
The present invention comprises compounds of the general formula (1) (See formula (1)) wherein the radicals R1 to R4, X1, X2, X3, L1 and L2 are defined as in claim 1, which are suitable for treatment of diseases that are characterized by excessive or abnormal cell proliferation, as well as their use in such a treatment. |